OYSTER POINT PHARMA INC
OYSTER POINT PHARMA INC logo
OYST

OYSTER POINT PHARMA INC (OYST)

$11.180.18%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$11.13
Day's Range
$11.25
$3.46
52-Week Range
$19.98
1 month return38.37%
3 month return78.03%
1 year return9.07%
5 year return40.47%

Company Information

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma's lead product candidate, OC-01 (varenicline) nasal spray, a highly selective cholinergic agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. In pre-clinical and clinical studies, OC-01 (varenicline) nasal spray was shown to have a novel mechanism of action via activation of the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the lacrimal functional unit.
OrganizationOYSTER POINT PHARMA INC
Employees303
CEODr. Jeffrey Nau MMS, Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 4 analysts ratings

Buy
75%
Buy
25%
Hold
0%
Sell

Based on 4 Wall street analysts offering stock ratings for OYSTER POINT PHARMA INC(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 132.56%

Current

$11.18

Target

$26.0

Recommendation Trend

Based on 4 analyst

Current1M Ago3M Ago
Buy
3
10
9
Hold
1
1
2
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
300.7M
Book Value
$3.75
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.95
Wall Street Target Price
26.0

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.95
Enterprise Value
326.3M
Enterprise Value/Revenue
16.66
Enterprise Value/Ebitda
-1.99

Technicals

Beta
1.19
50 Day MA
8.32
200 Day MA
7.38

Institutional Holdings

NEA Management Company, LLC

22.08%

Invus Financial Advisors, LLC

10.32%

RTW INVESTMENTS, LLC

7.67%

Point72 Asset Management, L.P.

7.04%

Paradigm Biocapital Advisors LP

6.14%

Kohlberg Kravis Roberts & Co LP

3.87%

Discover more

Frequently Asked Questions

What is OYSTER POINT PHARMA INC share price today?

Can Indians buy OYSTER POINT PHARMA INC shares?

How can I buy OYSTER POINT PHARMA INC shares from India?

Can Fractional shares of OYSTER POINT PHARMA INC be purchased?

What are the documents required to start investing in OYSTER POINT PHARMA INC stocks?

What are today’s High and Low prices of OYSTER POINT PHARMA INC?

What are today’s traded volumes of OYSTER POINT PHARMA INC?

What is today’s market capitalisation of OYSTER POINT PHARMA INC?

What is the 52 Week High and Low Range of OYSTER POINT PHARMA INC?

How much percentage OYSTER POINT PHARMA INC is down from its 52 Week High?

How much percentage OYSTER POINT PHARMA INC is up from its 52 Week low?

What are the historical returns of OYSTER POINT PHARMA INC?

Who is the Chief Executive Officer (CEO) of OYSTER POINT PHARMA INC?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*